BIOLINERX
Careers | Contact Us
search

Press Releases
November 9, 2015
Management to hold a conference call at 10:00 a.m. EST
November 5, 2015
Data strongly suggest BL-8040 has potent anti-leukemic activity in combination with Ara-C in AML

Results to be presented at 2015 ASH Annual Meeting
September 10, 2015
Study collaboration with MD Anderson Cancer Center will assess
BL-8040 as combination treatment with immunosuppressants
August 17, 2015
Phase 2b study, as consolidation treatment for AML patients responding to standard induction treatment, will enroll up to 194 patients, randomized in 1:1 ratio, at up to 25 sites in Germany 

Study is first of three additional clinical studies for BL-8040 platform expected to commence during 2015 
August 13, 2015
Management to hold a conference call at 10:00 a.m. EDT
111-120  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next